![]() |
|
|
Vol. 281, Issue 3, 1422-1430, 1997
Department of Anatomy and Cell Biology (P.G.F., K.S.C., T.F.D.) and
Departments of
Medicine and Pharmacology & Toxicology (P.G.F., G.M.R.),
Queen's University, Kingston, Ontario, Canada
Cytotoxicities induced by 1,1-dichloroethylene (DCE) are ascribed to
cytochrome P450-dependent metabolism to an epoxide. Conjugation of the
DCE-epoxide with glutathione (GSH) results in the formation of the
conjugates 2-S-glutathionyl acetate (GTA) and
2-(S-glutathionyl) acetyl glutathione (GAG); GAG undergoes
hydrolysis to form GTA, and thus GTA is a major metabolite of DCE
metabolism. Our objective is to develop an antiserum against the
chemically synthesized GTA, and for immunization, we have used a hapten
that consists of GTA conjugated to bovine serum albumin (BSA) as the
carrier protein and glutaraldehyde (GLUT) as a chemical cross-linker. The antisera were raised in rabbits and were characterized by using the
following synthesized structural analogs: GTA, glycine-GLUT-BSA (GLY-GLUT-BSA), GTA-GLUT-ovalbumin (GTA-GLUT-OVB),
GTA-1-ethyl-3-(3-dimethylaminopropyl) carbodiimide-BSA (GTA-EDC-BSA),
TRIS-GLUT-BSA, glutathione-GLUT-BSA (GSH-GLUT-BSA). The enzyme-linked
immunosorbent assay (ELISA) and slot immunoblotting were used to
characterize the specificity of the antisera. Noncompetitive ELISA
experiments showed that the reaction of the antiserum with the antigen
was concentration-dependent. In the competitive ELISA, GTA-GLUT-BSA
inhibited binding efficiently; in contrast, the unconjugated GTA did
not inhibit binding to the antigen. Competitive studies with the other
analogs indicated low or minimal reactivities with the antibodies,
which were blocked by incubation with GLY-GLUT-BSA. However, there was
residual reactivity with the antigen that was not competitively
inhibited by either the GTA-EDC-BSA or the GSH-GLUT-BSA conjugates.
Slot-blotting experiments confirmed the findings of the ELISA studies
and revealed high specificity of the antiserum to detect the hapten.
These results demonstrated the successful development of polyclonal antibodies to detect GTA and hence DCE-epoxide.